Topic: Actos
Confirm your Subscription | Having trouble viewing this e-mail click here | To unsubscribe click here. September 22, 2010 Fondaparinux appears to be safe and effective for reducing symptomatic superficial-vein thrombosis of the legs and may reduce the risk of that condition ...
A new study finds that the risk of heart attacks or death after taking the glucose-lowering diabetes drugs Avandia and Actos are about the same.. This is a direct contradiction to numerous other studies that found that the risk was elevated for ...
A new study finds that the risk of heart attacks or death after taking the glucose-lowering diabetes drugs Avandia and Actos are about the same.. This is a direct contradiction to numerous other studies that found that the risk was elevated for ...
According to data pooled from several large clinical trials, the diabetes drug Avandia does raise the odds of having a heart attack, bolstering the argument that the drug's risks might outweigh its benefits in people with type 2 diabetes.. Avandia did not, ...
Two new studies link the drug to increased heart risks just weeks before the FDA will consider whether it should remain on the market. June 28--The diabetes drug Avandia, once the world's top-selling diabetes medication, took two more hits Monday with one ...
Patients who take the controversial diabetes drug Avandia are more likely to have a stroke or heart failure, or die, than those who take a rival drug, a survey of more than 200,000 insurance records has revealed. The finding, published June 28 ...
Ahead of FDA hearing, new report ties diabetes pill to more heart problems, deaths than rivalA new study led by a federal drug safety expert ties the controversial diabetes drug Avandia to a higher risk of heart problems, strokes and deaths in ...
The safety of Avandia (rosiglitazone, GlaxoSmithKline) is being questioned again, this time by the U.S. Senate. The committee also revealed that at least two FDA safety investigators recommended that Avandia be taken off the market because of the risk of cardiac events. ...
The blockbuster type 2 diabetes drug Avandia raises users' odds for heart attack and heart failure and should be removed from the market, according to confidential government reports.. The New York Times on Saturday reported on documents from the U.S. Food and ...
This coming Monday, a panel of two dozen scientists called together by the U.S. Food and Drug Administration will weigh the risks and benefits of GlaxoSmithKline's diabetes drug Avandia, which was linked to an increased risk of heart attack in a well-publicized ...
From Around the Web
Video Gallery
-
Actos (Pioglitazone) and Heart Disease
Clip courtesy of www.medstores.net Actos (Pioglitazone) is a ...2010-08-29 -
Actos -- Bladder Cancer and Other Complications
Sometimes the potentially ugly complications reveal themselves during animal and ...2011-08-31 -
Pioglitazone (Actos) - News Segment
www.medstores.net - Pioglitazone (Actos) Slows Atherosclerotic Process Better than ...2010-08-29
